Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksME Group Regulatory News (MEGP)

Share Price Information for ME Group (MEGP)

Share Price is delayed by 15 minutes
Get Live Data
104.40    4.00 (3.98%)
Bid:
115.00
Ask:
99.20
Spread: -15.80 (-13.739%)
Market Cap: £391.13m
MEGP Live PriceLast checked at - London Stock Exchange

Intraday ME Group Share Chart

Form 8 - Public Opening Position (ME Group Intl.)

27 Jun 2025 15:48

RNS Number : 8241O
ME Group International PLC
27 June 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

ME Group International plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ME Group International plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

26 June 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 0.5 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

A) Interests in ordinary shares of ME Group International plc beneficially held by the directors of ME Group International plc (including their close relatives and related trusts)

 

Name

Number of ME Group International plc ordinary shares

Percentage of issued ordinary share capital of ME Group International plc (%)

Sir John Lewis OBE

25,000

0.00

Serge Crasnianski (and his close relatives)

138,058,091

36.57

Françoise Coutaz-Replan

200,000

0.05

Total

138,281,841

36.63

 

 

 

 

 

B) Interests held as options or awards under the Executive Share Option Scheme held by directors of ME Group International plc in ordinary shares in ME Group International plc

 

 

Director name

Date of grant

Number of ordinary shares (under option)

Exercisable from

Expiry date

Exercise price (per share) (£)

Serge Crasnianski

27 August 2019

564,752

27 August 2022

27 August 2026

1.014

5 August 2021

1,000,000

5 August 2024

4 August 2028

0.775

Tania Crasnianski

5 August 2021

96,774

5 August 2024

4 August 2028

0.775

12 May 2022

100,000

12 May 2025

11 May 2029

0.6873

4 April 2023

100,000

4 April 2026

3 April 2030

1.267

Jean-Marc Janailhac

5 August 2021

400,000

5 August 2024

4 August 2028

0.775

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

27 June 2025

Contact name:

Del Mansi

Telephone number:

01372 455 541

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEESEMFLWEISELM
Date   Source Headline
1st Jul 20267:00 amRNSVoting Rights and Capital
22nd Jun 202610:35 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 202611:00 amRNSVoting Rights and Capital
1st Jun 20267:00 amRNSTrading Update
28th May 20262:12 pmRNSHolding(s) in Company
6th May 20268:00 amRNSVoting Rights and Capital
30th Apr 20265:05 pmRNSDirector/PDMR Shareholding
30th Apr 20265:03 pmRNSDirector/PDMR Shareholding
28th Apr 202612:30 pmRNSChange of duties of Executive Director
24th Apr 202612:46 pmRNSResult of AGM
21st Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20265:48 pmRNSDirector/PDMR Shareholding
13th Apr 202610:24 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNS-RNew partnership with ASDA
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:02 amRNS-RNotice of Investor Presentation
23rd Mar 20267:01 amRNSLaunch of Share Buyback Programme
23rd Mar 20267:00 amRNS2025 Annual Results
12th Mar 20261:06 pmRNSUpdate-delay in FY25 Audited Financial Statements
2nd Mar 20267:00 amRNS-RAppointment of Chief Operating Officer
26th Feb 20265:22 pmRNSHolding(s) in Company
26th Feb 202611:35 amRNSResult of GM and Share Buyback Programme
25th Feb 20267:00 amRNSDelay in FY25 Audited Financial Statements
16th Feb 20267:00 amRNS-RNotice of Investor Presentation
13th Feb 20267:00 amRNSNotice of Annual Results
10th Feb 20262:30 pmRNSNotice of GM, Share Buyback and Rule 9 waiver
2nd Feb 20265:51 pmRNSHolding(s) in Company
2nd Feb 20267:00 amRNSAppointment of Deputy CEO
19th Jan 20267:00 amRNSCorporate Broker Update
14th Jan 202611:09 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSResult of secondary placing in ME Group
13th Jan 20264:37 pmRNSProposed secondary placing in ME Group
10th Dec 20253:35 pmRNSForm 8.3 ME Group International Plc Amendment
8th Dec 202510:10 amPRNForm 8.3 - ME Group International Plc
5th Dec 20255:15 pmRNSDisclosure Table
5th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) ME Group International PLC
5th Dec 202510:24 amPRNForm 8.3 - ME Group International Plc
5th Dec 20258:55 amRNSTermination of Offer Period
4th Dec 20253:20 pmRNSForm 8.3 - ME Group International plc
4th Dec 20252:55 pmRNSForm 8.3 - ME GROUP INTERNATIONAL PLC
4th Dec 20251:01 pmRNSForm 8.3 - ME Group International plc
4th Dec 202512:00 pmRNSForm 8.5 (EPT/RI) ME Group International PLC
4th Dec 202511:49 amRNSForm 8.3 - ME Group International Plc
4th Dec 20258:44 amPRNForm 8.3 - ME Group International Plc
3rd Dec 20253:10 pmRNSForm 8.3 - ME GROUP INTERNATIONAL PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.